SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Better Therapeutics, Inc. (BTTX) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 26/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
25/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — BTTX
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-1.69
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2019 |
$-0.25 |
$18K |
$-5.8M |
-32194.4% |
| 2020 |
$-0.85 |
$8K |
$-6.39M |
-79837.5% |
| 2021 |
$-1.71 |
$0.00 |
$-40.34M |
- |
| 2022 |
$-1.69 |
$0.00 |
$-39.76M |
- |
